Evidence map›Paper›PMID 39751380›Full record

ArticleeLife2025

Diversity in Notch ligand-receptor signaling interactions.

Rachael Kuintzle, Leah A Santat, Michael B Elowitz

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Developmental regulation of intestinalbioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Functional Divergence ofInternational journal of molecular sciences · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Rachael KuintzleDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States.ORCID https://orcid.org/0000-0002-1035-4983
Leah A SantatDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States.ORCID https://orcid.org/0000-0003-0511-9740
Michael B ElowitzDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States.ORCID https://orcid.org/0000-0002-1221-0967

Funding

Quantitative Single-Cell Analysis of Mammalian Notch Signaling StatesR01HD075335 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ELOWITZ, MICHAEL B · 2012 to 2024
$3.7M
Elucidating the Dynamic Code of the Notch Signaling PathwayF31HD100185 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI KUINTZLE, RACHAEL C · 2019 to 2022
$138k
NICHD NIH HHS F31 HD100185NICHD NIH HHS R01 HD075335NIH HHS F31 HD100185NIH HHS R01 HD7335C
6 · The paper itself

Abstract

The Notch signaling pathway uses families of ligands and receptors to transmit signals to nearby cells. These components are expressed in diverse combinations in different cell types, interact in a many-to-many fashion, both within the same cell (in cis) and between cells (in trans), and their interactions are modulated by Fringe glycosyltransferases. A fundamental question is how the strength of Notch signaling depends on which pathway components are expressed, at what levels, and in which cells. Here, we used a quantitative, bottom-up, cell-based approach to systematically characterize trans-activation, cis-inhibition, and cis-activation signaling efficiencies across a range of ligand and Fringe expression levels in Chinese hamster and mouse cell lines. Each ligand (Dll1, Dll4, Jag1, and Jag2) and receptor variant (Notch1 and Notch2) analyzed here exhibited a unique profile of interactions, Fringe dependence, and signaling outcomes. All four ligands were able to bind receptors in cis and in trans, and all ligands trans-activated both receptors, although Jag1-Notch1 signaling was substantially weaker than other ligand-receptor combinations. Cis-interactions were predominantly inhibitory, with the exception of the Dll1- and Dll4-Notch2 pairs, which exhibited cis-activation stronger than trans-activation. Lfng strengthened Delta-mediated trans-activation and weakened Jagged-mediated trans-activation for both receptors. Finally, cis-ligands showed diverse cis-inhibition strengths, which depended on the identity of the trans-ligand as well as the receptor. The map of receptor-ligand-Fringe interaction outcomes revealed here should help guide rational perturbation and control of the Notch pathway.

Indexed as

Calcium-Binding ProteinsIntercellular Signaling Peptides and ProteinsJagged-1 ProteinMembrane ProteinsSignal TransductionAdaptor Proteins, Signal TransducingAnimalsCell LineCHO CellsCricetinaeCricetulusGlycosyltransferasesIntracellular Signaling Peptides and ProteinsJagged-2 ProteinLigandsMiceAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsDlk1 protein, mouseDLL4 protein, mouseGlycosyltransferasesIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsJag1 protein, mouseJag2 protein, mouseJagged-1 ProteinJagged-2 ProteinLfng protein, mouseLigandsMembrane ProteinsNotch1 protein, mouseNotch2 protein, mouseReceptor, Notch1Receptor, Notch2Receptors, NotchSerrate-Jagged Proteinscell signalingcomputational biologydevelopmental biologymouseNotch signalingquantitative biologysystems biology

Identifiers

PMID39751380
PMCPMC11698495

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.